Books on the topic 'Health services regulation'

Rogers, Peter. National enforcement priorities for local authority regulatory services. London: Better Regulation Executive, 2007.

Dixon, Anna. Economic regulation in health care: What can we learn from other regulators? London: The King's Fund, 2011.

Auditor, Nevada Legislature Legislative. Audit report, State of Nevada, Department of Health and Human Services, Health Division, inspection programs. Carson City, Nev: Legislative Counsel Bureau, 2009.

Rizzo, John Arthur. Optimal regulation of multiply-regulated industries: The case of physician services. Cambridge, MA: National Bureau of Economic Research, 1994.

Washington (State). In-Home Services Agencies Round Table. State regulation of home health, hospice, home care (Chapter 70.127 RCW). Olympia, Wash: Washington State Dept. of Health, 1999.

service), SpringerLink (Online, ed. Evidence-Based School Mental Health Services: Affect Education, Emotion Regulation Training, and Cognitive Behavioral Therapy. New York, NY: Springer Science+Business Media, LLC, 2011.

Ridenour, Amy. Shattered lives: 100 victims of government health care. Washington, D.C: National Center for Public Policy Research, 2009.

Ryan, Balis, and National Center for Public Policy Research., eds. Shattered lives: 100 victims of government health care. Washington, D.C: National Center for Public Policy Research, 2009.

Opportunities, United States Congress House Committee on Small Business Subcommittee on Regulation and Business. Rural health care: Hearing before the Subcommittee on Regulation and Business Opportunities of the Committee on Small Business, House of Representatives, One Hundredth Congress, second session, Baker, OR, August 18, 1988. Washington: U.S. G.P.O., 1988.

Mant, D. C. Building regulation and health: A report to the Building Research Establishment concerning the influence on health of building fabric and services controlled or controllable by Building Regulations. Watford: Building Research Establishment, 1986.

1946-, Berwick Donald M., ed. New rules: Regulation, markets, and the quality of American health care. San Francisco: Jossey-Bass Publishers, 1996.

name, No. Government relations in the health care industry. Westport, CT: Quorum Books, 2003.

Trillion dollar scam: Exploding health care fraud. Boca Raton: Universal Publishers, 2008.

Georgia. Dept. of Audits and Accounts. Performance audit, Department of Human Resources, Office of Regulatory Services, Health Care Facilities Regulation Program, December, 1989. Atlanta, Ga: State of Georgia, Dept. of Audits, 1989.

Minnesota. Dept. of Health. Home Care Advisory Task Force. Recommendations for the regulation of home care providers: Report of the Home Care Advisory Task Force to the Commissioner of Health. [Minneapolis]: Minnesota Dept. of Health, 1989.

Rao, S. L. The role of the private health care provider in rural India: Retail distribution, drug price and the need for adequate regulation to protect the vulnerable poor. New Delhi: Bazaar Chintan, 2004.

Institute of Medicine (U.S.). Committee on the Role of Institutional Review Boards in Health Services Research Data Privacy Protection. Protecting data privacy in health services research. Washington, D.C: National Academy Press, 2000.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

United, States Congress House Committee on Small Business Subcommittee on Regulation Business Opportunities and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

United, States Congress House Committee on Small Business Subcommittee on Regulation Business Opportunities and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. U.S. pharmaceutical research and development, and its impact on women's health: The technology deficit in contraception, cancer, and reproductive disease and conditions : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Camden, NJ, May 8, 1992. Washington: U.S. G.P.O., 1992.

General, Michigan Office of the Auditor. Audit report: Performance audit, Enforcement Program, Bureau of Health Services, Department of Licensing and Regulation, May 1, 1985 through January 31, 1989. [Lansing, Mich.]: The Office, 1990.

Britain, Great. National Health Service, England: The National Health Service (General Dental Services) Amendment Regulations 2001. London: Stationery Office, 2001.

New Jersey. Legislature. General Assembly. Regulatory Oversight Committee. Committee meeting of Assembly Regulatory Oversight Committee: Assembly bill no. 2355 (requires impact statement for any proposed regulation affecting volunteer ambulance squad and fire company) ; Testimony on the status of removing adjudicated juveniles with mental illness from the juvenile correctional facilities to provide them with mental health treatment : [January 13, 2005, Trenton, New Jersey]. Trenton, N.J: The Unit, 2005.

Examining federal regulation of mobile medical apps and other health software: Hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, November 19, 2013. Washington: U.S. Government Printing Office, 2014.

Nadel, M. V. Health insurance regulation: National portability standards would facilitate changing health plans : statement of Mark V. Nadel, Associate Director, National and Public Health Issues, Health, Education, and Human Services Division, before the Committee on Labor and Human Resources, United States Senate. Washington, D.C. (P.O. Box 37050, Washington 20013): The Office, 1995.

Great Britain. National Assembly for Wales. Regulation and inspection of social and health care services in Wales: A commission for care standards in Wales : consultation paper = Rheoleiddio ac arolygu gwasanaethau cymdeithasol a gofal iechyd yng Nghymru : papur ymgynghori. [Cardiff]: National Assembly for Wales = Cynulliad Cenedlaethol Cymru, 1999.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. Impact of the high-cost of long-term contraceptive products on federally sponsored family planning clinics, welfare reform efforts, and women's health initiatives: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, March 18, 1994. Washington: U.S. G.P.O., 1994.

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology. Impact of the high-cost of long-term contraceptive products on federally sponsored family planning clinics, welfare reform efforts, and women's health initiatives: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, March 18, 1994. Washington: U.S. G.P.O., 1994.

United, States Congress House Committee on Small Business Subcommittee on Regulation Business Opportunities and Technology. Impact of the high-cost of long-term contraceptive products on federally sponsored family planning clinics, welfare reform efforts, and women's health initiatives: Hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, March 18, 1994. Washington: U.S. G.P.O., 1994.

Services, California Legislature Senate Committee on Health and Human. Lead content in Mexican candy: A serious threat? : joint informational hearing, Senate Health and Human Services Committee and the Senate Select Committee on Government Oversight. Sacramento, CA: Senate Publications, 2004.

The burden of health services regulation: Hearing before the Joint Economic Committee, Congress of the United States, One Hundred Eighth Congress, second session, May 13, 2004. Washington: U.S. G.P.O., 2004.

Mao yi yu gong gong wei sheng zhi fa lu wen ti. Taibei Shi: Yuan zhao chu ban gong si, 2009.

Great Britain. Parliament. House of Commons. Fifth Standing Committee on Delegated Legislation. National health service (General medical services) amendment (no.2) regulations 1999: National health service (General medical services)(Scotland)amendment (no.3) regulations 1999, Tuesday 27 July 1999. London: Stationery Office, 1999.

United States. Congress. House. A bill to prohibit the Secretary of Health and Human Services from promulgating any regulation, rule, or other order if the effect of such regulation, rule, or order is to eliminate or modify any requirement under the Medicare program under title XVIII of the Social Security Act for physician supervision of anesthesia services, as such requirement was in effect on December 31, 1997. [Washington, D.C.?]: [United States Government Printing Office], 1998.

The EU paediatric regulation. Amsterdam: IOS Press, 2009.

The EU paediatric regulation. Amsterdam: IOS Press, 2009.

The EU paediatric regulation. Amsterdam: IOS Press, 2009.

Florida. Legislature. Senate. Committee on Health Care., ed. A review of home health agency certificate-of-need regulation. [Tallahassee]: The Committee, 1995.

Counselling Services for Sterilisation, Vasectomy and Termination of Pregnancy. Policy Studies Institute, 1985.

Macklem, Gayle L. Evidence-Based School Mental Health Services: Affect Education, Emotion Regulation Training, and Cognitive Behavioral Therapy. Springer, 2011.

Macklem, Gayle L. L. Evidence-Based School Mental Health Services: Affect Education, Emotion Regulation Training, and Cognitive Behavioral Therapy. Springer, 2014.

Great Britain. Dept. of Health., ed. Response to consultation on the framework for the registration of health and adult social care providers and consultation on draft regulations: The future regulation of health and adult social care in England : health and social care working together in partnership. London: Dept. of Health, 2009.

An evaluation, regulation of nursing homes and assisted living facilities, Department of Health and Family Services. Madison, WI: Wisconsin Legislative Audit Bureau, 2002.

Britain, Great. Northern Ireland: The Health and Personal Social Services (Quality, Improvement and Regulation) (Northern Ireland) Order 2003. London: Stationery Office, 2003.

(Editor), Peggy Leatt, and Joseph Mapa (Editor), eds. Government Relations in the Health Care Industry. Praeger Publishers, 2003.